BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17502456)

  • 1. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
    Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
    Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
    Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.
    Binné UK; Classon MK; Dick FA; Wei W; Rape M; Kaelin WG; Näär AM; Dyson NJ
    Nat Cell Biol; 2007 Feb; 9(2):225-32. PubMed ID: 17187060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence.
    Kuo YL; Giam CZ
    EMBO J; 2006 Apr; 25(8):1741-52. PubMed ID: 16601696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.
    Liu W; Wu G; Li W; Lobur D; Wan Y
    Mol Cell Biol; 2007 Apr; 27(8):2967-79. PubMed ID: 17283060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
    Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
    Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src.
    Cen B; Li H; Weinstein IB
    J Biol Chem; 2009 Feb; 284(8):5265-76. PubMed ID: 19112177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation.
    Vosper J; Masuccio A; Kullmann M; Ploner C; Geley S; Hengst L
    Oncotarget; 2015 Feb; 6(5):2889-902. PubMed ID: 25605247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
    Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
    J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling.
    Wang W; Ungermannova D; Jin J; Harper JW; Liu X
    Oncogene; 2004 Feb; 23(5):1064-75. PubMed ID: 14676846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
    Su B; Chen X; Zhong C; Guo N; He J; Fan Y
    J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription.
    Center DM; Cruikshank WW; Zhang Y
    J Immunol; 2004 Feb; 172(3):1654-60. PubMed ID: 14734747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
    Roy S; Kaur M; Agarwal C; Tecklenburg M; Sclafani RA; Agarwal R
    Mol Cancer Ther; 2007 Oct; 6(10):2696-707. PubMed ID: 17938263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.